In Vitro and In Vivo characterizations of pichinde viral nucleoprotein exoribonuclease functions

Journal of Virology

Volumn 89, Issue 13, 2015, Pages 6595-6607

  Huang, Qinfeng ^a,b   Shao, Junjie ^a   Lan, Shuiyun ^c   Zhou, Yanqin ^a,d   Xing, Junji ^a   Dong, Changjiang ^e   Liang, Yuying ^a   Ly, Hinh ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b INSTITUTE OF PLANT PROTECTION   (China)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^e UNIVERSITY OF EAST ANGLIA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EXORIBONUCLEASE; INTERFERON; VIRUS NUCLEOPROTEIN; NUCLEOPROTEIN;

A549 CELL LINE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARENAVIRUS INFECTION; ARTICLE; CONTROLLED STUDY; CYTOKINE RESPONSE; ENZYME ACTIVITY; ENZYME MECHANISM; GENE REPRESSION; GUINEA PIG; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MALE; MUTANT; MUTATION; NONHUMAN; PICHINDE VIRUS; PRIORITY JOURNAL; RNA REPLICATION; RNA SYNTHESIS; VERO CELL LINE; VIROGENESIS; VIRUS VIRULENCE; WILD TYPE; AMINO ACID SUBSTITUTION; ANIMAL; CELL LINE; DISEASE MODEL; DNA MUTATIONAL ANALYSIS; ENZYMOLOGY; GENETICS; HOST PATHOGEN INTERACTION; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN MOTIF; VIROLOGY; VIRUS REPLICATION;

ANIMALIA; ARENAVIRUS; CAVIA; MACHUPO VIRUS; PICHINDE VIRUS;

AMINO ACID MOTIFS; AMINO ACID SUBSTITUTION; ANIMALS; ARENAVIRIDAE INFECTIONS; CELL LINE; DISEASE MODELS, ANIMAL; DNA MUTATIONAL ANALYSIS; EXORIBONUCLEASES; GUINEA PIGS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNE EVASION; MALE; NUCLEOPROTEINS; PICHINDE VIRUS; VIRUS REPLICATION;

EID: 84930885840     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00009-15     Document Type: Article

References (44)

1. McLay L, Ansari A, Liang Y, Ly H. 2013. Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever. Antiviral Res 97:81-92. http://dx.doi.org/10.1016/j.antiviral.2012.12.003.
2. McLay L, Liang Y, Ly H. 2014. Comparative analysis of disease pathogenesis and molecular mechanisms of New World and Old World arenavirus infections. J Gen Virol 95:1-15. http://dx.doi.org/10.1099/vir.0.057000-0.
3. Jahrling PB, Hesse RA, Rhoderick JB, Elwell MA, Moe JB. 1981. Pathogenesis of a Pichinde virus strain adapted to produce lethal infections in guinea pigs. Infect Immun 32:872-880.
4. Aronson JF, Herzog NK, Jerrells TR. 1994. Pathological and virological features of arenavirus disease in guinea pigs. Comparison of two Pichinde virus strains. Am J Pathol 145:228-235.
5. Lan S, McLay Schelde L, Wang J, Kumar N, Ly H, Liang Y. 2009. Development of infectious clones for virulent and avirulent Pichinde viruses: a model virus to study arenavirus-induced hemorrhagic fevers. J Virol 83:6357-6362. http://dx.doi.org/10.1128/JVI.00019-09.
6. Buchmeier MJ, De La Torre JC, Peters CJ. 2007. Arenaviridae: the viruses and their replication, p 1791-1827. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
7. Burri DJ, da Palma JR, Kunz S, Pasquato A. 2012. Envelope glycoprotein of arenaviruses. Viruses 4:2162-2181. http://dx.doi.org/10.3390/v4102162.
8. Pinschewer DD, Perez M, de la Torre JC. 2003. Role of the virus nucleoprotein in the regulation of lymphocytic choriomeningitis virus transcription and RNA replication. J Virol 77:3882-3887. http://dx.doi .org/10.1128/JVI.77.6.3882-3887.2003.
9. Martinez-Sobrido L, Zuniga EI, Rosario D, Garcia-Sastre A, de la Torre JC. 2006. Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 80:9192-9199. http://dx.doi.org/10.1128/JVI.00555-06.
10. Qi X, Lan S, Wang W, Schelde LM, Dong H, Wallat GD, Ly H, Liang Y, Dong C. 2010. Cap binding and immune evasion revealed by Lassa nucleoprotein structure. Nature 468:779-783. http://dx.doi.org/10.1038/nature09605.
11. Hastie KM, Liu T, Li S, King LB, Ngo N, Zandonatti MA, Woods VL, Jr, de la Torre JC, Saphire EO. 2011. Crystal structure of the Lassa virus nucleoprotein-RNA complex reveals a gating mechanism for RNA binding. Proc Natl Acad Sci USA 108:19365-19370. http://dx.doi.org/10.1073/pnas.1108515108.
12. Jiang X, Huang Q, Wang W, Dong H, Ly H, Liang Y, Dong C. 2013. Structures of arenaviral nucleoproteins with triphosphate dsRNA reveal a unique mechanism of immune suppression. J Biol Chem 288:16949-16959. http://dx.doi.org/10.1074/jbc.M112.420521.
13. Hastie KM, King LB, Zandonatti MA, Saphire EO. 2012. Structural basis for the dsRNA specificity of the Lassa virus NP exonuclease. PLoS One 7:e44211. http://dx.doi.org/10.1371/journal.pone.0044211.
14. Hastie KM, Kimberlin CR, Zandonatti MA, Macrae IJ, Saphire EO. 2011. Structure of the Lassa virus nucleoprotein reveals a dsRNA-specific 3' to 5' exonuclease activity essential for immune suppression. Proc Natl Acad Sci USA 108:2396-2401. http://dx.doi.org/10.1073/pnas.1016404108.
15. Fehling SK, Lennartz F, Strecker T. 2012. Multifunctional nature of the arenavirus RING finger protein Z. Viruses 4:2973-3011. http://dx.doi.org/10.3390/v4112973.
16. Salvato M, Shimomaye E, Oldstone MB. 1989. The primary structure of the lymphocytic choriomeningitis virus L gene encodes a putative RNA polymerase. Virology 169:377-384. http://dx.doi.org/10.1016/0042-6822(89)90163-3.
17. Sanchez AB, de la Torre JC. 2005. Genetic and biochemical evidence for an oligomeric structure of the functional L polymerase of the prototypic arenavirus lymphocytic choriomeningitis virus. J Virol 79:7262-7268. http://dx.doi.org/10.1128/JVI.79.11.7262-7268.2005.
18. Takeuchi O, Akira S. 2009. Innate immunity to virus infection. Immunol Rev 227:75-86. http://dx.doi.org/10.1111/j.1600-065X.2008.00737.x.
19. Stetson DB, Medzhitov R. 2006. Type I interferons in host defense. Immunity 25:373-381. http://dx.doi.org/10.1016/j.immuni.2006.08.007.
20. Ng CT, Snell LM, Brooks DG, Oldstone MB. 2013. Networking at the level of host immunity: immune cell interactions during persistent viral infections. Cell Host Microbe 13:652-664. http://dx.doi.org/10.1016/j .chom.2013.05.014.
21. Huber JP, Farrar JD. 2011. Regulation of effector and memory T-cell functions by type I interferon. Immunology 132:466-474. http://dx.doi .org/10.1111/j.1365-2567.2011.03412.x.
22. Carnec X, Baize S, Reynard S, Diancourt L, Caro V, Tordo N, Bouloy M. 2011. Lassa virus nucleoprotein mutants generated by reverse genetics induce a robust type I interferon response inhumandendritic cells and macrophages. J Virol 85:12093-12097. http://dx.doi.org/10.1128/JVI.00429-11.
23. Lan S, McLay L, Aronson J, Ly H, Liang Y. 2008. Genome comparison of virulent and avirulent strains of the Pichinde arenavirus. Arch Virol 153:1241-1250. http://dx.doi.org/10.1007/s00705-008-0101-2.
24. Park MS, Shaw ML, Munoz-Jordan J, Cros JF, Nakaya T, Bouvier N, Palese P, Garcia-Sastre A, Basler CF. 2003. Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDVVprotein and the Nipah virus V, W, andCproteins. J Virol 77:1501-1511. http://dx.doi.org/10.1128/JVI.77.2.1501-1511.2003.
25. McLay L, Lan S, Ansari A, Liang Y, Ly H. 2013. Identification of virulence determinants within the L genomic segment of the Pichinde arenavirus. J Virol 87:6635-6643. http://dx.doi.org/10.1128/JVI.00044-13.
26. Pythoud C, Rodrigo WW, Pasqual G, Rothenberger S, Martinez-Sobrido L, de la Torre JC, Kunz S. 2012. Arenavirus nucleoprotein targets interferon regulatory factor-activating kinase IKKepsilon. J Virol 86:7728-7738. http://dx.doi.org/10.1128/JVI.00187-12.
27. Kumar N, Wang J, Lan S, Danzy S, McLay Schelde L, Seladi-Schulman J, Ly H, Liang Y. 2012. Characterization of virulence-associated determinants in the envelope glycoprotein of Pichinde virus. Virology 433:97-103. http://dx.doi.org/10.1016/j.virol.2012.07.009.
28. Asper M, Sternsdorf T, Hass M, Drosten C, Rhode A, Schmitz H, Gunther S. 2004. Inhibition of different Lassa virus strains by alpha and gamma interferons and comparison with a less pathogenic arenavirus. J Virol 78:3162-3169. http://dx.doi.org/10.1128/JVI.78.6.3162-3169.2004.
29. Baize S, Pannetier D, Faure C, Marianneau P, Marendat I, Georges-Courbot MC, Deubel V. 2006. Role of interferons in the control of Lassa virus replication in human dendritic cells and macrophages. Microbes Infect 8:1194-1202. http://dx.doi.org/10.1016/j.micinf.2006.02.002.
30. Fan L, Briese T, Lipkin WI. 2010. Z proteins of New World arenaviruses bind RIG-I and interfere with type I interferon induction. J Virol 84:1785-1791. http://dx.doi.org/10.1128/JVI.01362-09.
31. Xing J, Ly H, Liang Y. 2015. The Z proteins of pathogenic but not nonpathogenic arenaviruses inhibit the RIG-I-like receptor-dependent interferon production. J Virol 89:2944-2955. http://dx.doi.org/10.1128/JVI.03349-14.
32. Huang C, Kolokoltsova OA, Yun NE, Seregin AV, Poussard AL, Walker AG, Brasier AR, Zhao Y, Tian B, de la Torre JC, Paessler S. 2012. Junin virus infection activates the type I interferon pathway in a RIG-Idependent manner. PLoS Negl Trop Dis 6:e1659. http://dx.doi.org/10.1371/journal.pntd.0001659.
33. Groseth A, Hoenen T, Weber M, Wolff S, Herwig A, Kaufmann A, Becker S. 2011. Tacaribe virus but not Junin virus infection induces cytokine release from primary human monocytes and macrophages. PLoS Negl Trop Dis 5:e1137. http://dx.doi.org/10.1371/journal.pntd.0001137.
34. Trinchieri G. 2010. Type I interferon: friend or foe? J Exp Med 207:2053-2063. http://dx.doi.org/10.1084/jem.20101664.
35. Teijaro JR, Ng C, Lee AM, Sullivan BM, Sheehan KC, Welch M, Schreiber RD, de la Torre JC, Oldstone MB. 2013. Persistent LCMV infection is controlled by blockade of type I interferon signaling. Science 340:207-211. http://dx.doi.org/10.1126/science.1235214.
36. Wilson EB, Yamada DH, Elsaesser H, Herskovitz J, Deng J, Cheng G, Aronow BJ, Karp CL, Brooks DG. 2013. Blockade of chronic type I interferon signaling to control persistent LCMV infection. Science 340: 202-207. http://dx.doi.org/10.1126/science.1235208.
37. Yun NE, Poussard AL, Seregin AV, Walker AG, Smith JK, Aronson JF, Smith JN, Soong L, Paessler S. 2012. Functional interferon system is required for clearance of Lassa virus. J Virol 86:3389-3392. http://dx.doi .org/10.1128/JVI.06284-11.
38. Yun NE, Seregin AV, Walker DH, Popov VL, Walker AG, Smith JN, Miller M, de la Torre JC, Smith JK, Borisevich V, Fair JN, Wauquier N, Grant DS, Bockarie B, Bente D, Paessler S. 2013. Mice lacking functional STAT1 are highly susceptible to lethal infection with Lassa virus. J Virol 87:10908-10911. http://dx.doi.org/10.1128/JVI.01433-13.
39. Kolokoltsova OA, Yun NE, Poussard AL, Smith JK, Smith JN, Salazar M, Walker A, Tseng CT, Aronson JF, Paessler S. 2010. Mice lacking alpha/beta and gamma interferon receptors are susceptible to Junin virus infection. J Virol 84:13063-13067. http://dx.doi.org/10.1128/JVI.01389-10.
40. Bradfute SB, Stuthman KS, Shurtleff AC, Bavari S. 2011. A STAT-1 knockout mouse model for Machupo virus pathogenesis. Virol J 8:300. http://dx.doi.org/10.1186/1743-422X-8-300.
41. Patterson M, Seregin A, Huang C, Kolokoltsova O, Smith J, Miller M, Smith J, Yun N, Poussard A, Grant A, Tigabu B, Walker A, Paessler S. 2014. Rescue of a recombinant Machupo virus from cloned cDNAs and in vivo characterization in interferon (αβ/γ) receptor double knockout mice. J Virol 88:1914-1923. http://dx.doi.org/10.1128/JVI.02925-13.
42. Baize S, Marianneau P, Loth P, Reynard S, Journeaux A, Chevallier M, Tordo N, Deubel V, Contamin H. 2009. Early and strong immune responses are associated with control of viral replication and recovery in Lassa virus-infected cynomolgus monkeys. J Virol 83:5890-5903. http://dx.doi.org/10.1128/JVI.01948-08.
43. Mahanty S, Bausch DG, Thomas RL, Goba A, Bah A, Peters CJ, Rollin PE. 2001. Low levels of interleukin-8 and interferon-inducible protein-10 in serum are associated with fatal infections in acute Lassa fever. J Infect Dis 183:1713-1721. http://dx.doi.org/10.1086/320722.
44. Grant A, Seregin A, Huang C, Kolokoltsova O, Brasier A, Peters C, Paessler S. 2012. Junin virus pathogenesis and virus replication. Viruses 4:2317-2339. http://dx.doi.org/10.3390/v4102317.